Description
CIPVILDIN 50 Tablet contains Vildagliptin IP 50mg as its active ingredient and is manufactured by Cipla Ltd. Vildagliptin is an oral anti-diabetic medication classified as a DPP-4 inhibitor (dipeptidyl peptidase-4 inhibitor). It is prescribed for the management of Type 2 Diabetes Mellitus, especially in cases where diet, exercise, and other single-agent therapies do not provide adequate blood sugar control.
Vildagliptin works by enhancing levels of incretin hormones (GLP-1 and GIP) in the body. These hormones increase glucose-dependent insulin release from the pancreas and decrease the secretion of glucagon, a hormone that raises blood sugar. As a result, vildagliptin supports better glycemic control by both boosting insulin production during high blood sugar and suppressing excess glucose release from the liver.
Patients may be prescribed CIPVILDIN 50 Tablet as monotherapy or in combination with other anti-diabetic agents such as metformin, sulfonylureas, or insulin, as directed by the treating physician. It is important to take this medicine at the same time every day, and dosage must be strictly determined by your healthcare provider. Most common side effects include headache, dizziness, upper respiratory tract infections, nausea, and rarely, mild hypoglycemia—especially when combined with other anti-diabetic medicines.
CIPVILDIN 50 Tablet is not recommended for patients with Type 1 diabetes, diabetic ketoacidosis, or those with severe liver or kidney impairment. Before starting this medicine, discuss your complete medical history—including all medicines and supplements—with your doctor. Regular monitoring of blood sugar and periodic assessment of kidney and liver function are advised for individuals on vildagliptin.
Take CIPVILDIN 50 Tablet exactly as prescribed and continue to follow your diabetes management plan including diet, exercise, and routine laboratory checkups for best results.
Leave a Reply